Analyst Ranking
Top 18%
#840 out of 4862 analysts
Average Return
+3.66%
Win Rate
40%49 out of 121
Risk vs Reward
Poor
Good

Mark Massaro's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Genedx Holdings CorpWGS
+776.23%$10.39$91.04
2024-04-21 -
2025-04-21
Strong Buy
Genedx Holdings CorpWGS
+433.33%$17.07$91.04
2024-04-29 -
2025-04-21
Strong Buy
Genedx Holdings CorpWGS
+247.61%$26.19$91.04
2024-06-25 -
2025-04-21
Strong Buy
Genedx Holdings CorpWGS
+178.24%$32.72$91.04
2024-07-30 -
2025-04-21
Strong Buy
Adaptive Biotechnologies CorpADPT
+171.43%$2.73$7.41
2024-04-03 -
2025-04-03
Strong Buy

Mark Massaro's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Tempus Ai IncTEM
1Strong Buy$60.00+46.41%Initiates Coverage On
a day ago
Adaptive Biotechnologies CorpADPT
4Strong Buy$9.00+31.77%Maintains
4 months ago
Exact Sciences CorpEXAS
14Strong Buy$75.00+74.01%Maintains
5 months ago
Personalis IncPSNL
1Strong Buy$7.00+121.52%Maintains
8 months ago
Zoetis IncZTS
2Strong Buy$225.00+53.22%Maintains
8 months ago
Natera IncNTRA
8Strong Buy$135.00-5.08%Maintains
8 months ago
Genedx Holdings CorpWGS
6Strong Buy$45.00-50.57%Maintains
9 months ago
Guardant Health IncGH
2Strong Buy$50.00+17.34%Maintains
9 months ago
Idexx Laboratories IncIDXX
1Strong Buy$580.00+42.63%Initiates Coverage On
9 months ago
Ginkgo Bioworks Holdings IncDNA
3Strong Sell$8.00+8.99%Maintains
10 months ago
Bionano Genomics IncBNGO
7Strong Buy$120.00+2,900.00%Maintains
a year ago
Akoya Biosciences IncAKYA
2Strong Buy$6.00+445.45%Maintains
a year ago
Neogenomics IncNEO
4Strong Buy$21.00+119.21%Maintains
a year ago
Maxcyte IncMXCT
3Strong Buy$8.00N/AMaintains
a year ago
Dermtech IncDMTKQ
4Strong Buy$2.00N/AMaintains
a year ago
Mdxhealth SaMDXH
7Strong Buy$8.00N/AMaintains
a year ago
Sophia Genetics SaSOPH
2Strong Buy$8.00N/AMaintains
a year ago
Talis Biomedical CorpTLIS
3Strong Sell$5.00N/AMaintains
2 years ago
Castle Biosciences IncCSTL
2Strong Buy$30.00N/AMaintains
2 years ago
Cue Health IncHLTHQ
4Strong Buy$3.00N/AMaintains
2 years ago
Renalytix PLCRNLXY
3Strong Buy$3.50N/AMaintains
2 years ago
Exagen IncXGN
3Strong Buy$5.00N/AMaintains
2 years ago
Caredx IncCDNA
2Strong Buy$25.00N/AMaintains
2 years ago
Lucid Diagnostics IncLUCD
2Strong Buy$3.50N/AMaintains
2 years ago
Lumiradx LtdLMDXF
1Strong Buy$4.00N/AMaintains
3 years ago
Phenomex IncCELL
2HoldN/AN/ADowngrades
3 years ago
T2 Biosystems IncTTOO
2HoldN/AN/ADowngrades
3 years ago
Quotient LtdQTNTQ
1Strong Buy$1.50N/AMaintains
3 years ago
Oncocyte CorpOCX
1Strong Buy$100.00N/AInitiates Coverage On
4 years ago
Chembio Diagnostics IncCEMI
1Strong Buy$12.00N/AMaintains
5 years ago
Labcorp Holdings IncLH
4Hold$155.00N/AMaintains
6 years ago
Genmark Diagnostics IncGNMK
4Strong Buy$9.00N/AMaintains
6 years ago
Quest Diagnostics IncDGX
3Strong Buy$105.00N/AMaintains
6 years ago
Hologic IncHOLX
3Hold$41.00N/AMaintains
7 years ago
Quidelortho CorpQDEL
4Strong Buy$80.00N/AMaintains
7 years ago
Genomic Health IncGHDX
3Strong Buy$62.00N/AMaintains
7 years ago
Illumina IncILMN
3Strong Buy$340.00N/AMaintains
7 years ago
Heska CorpHSKA
2Strong Buy$123.00N/AMaintains
7 years ago
Htg Molecular Diagnostics IncHTGMQ
2Strong Buy$1,260.00N/AMaintains
7 years ago
Abaxis IncABAX
1Hold$47.00N/AMaintains
7 years ago
Alere IncALR1
4Hold$56.00N/ADowngrades
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.